
Methylene Blue Solution
2% w/v, pharmaceutical grade
In stock · Dispatches 1-2 business days after payment

20 mg, lyophilised, research use only
Research use only, not for administration. We state this plainly rather than hiding it behind a brand name.
Retatrutide is an investigational single-molecule triple agonist at the GLP-1, GIP and glucagon receptors, currently in clinical trials and not approved by Health Canada, the FDA, the EMA or any other regulator anywhere. There is no approved indication and no completed long-term safety record. Supplied strictly as a research chemical for laboratory use, not for human or veterinary administration.
Presentation
$240.00 per vial
IMPORTANT
Nothing here is medical advice, and none of it is tailored to you. How much of anything a person should take depends on weight, other medication and history that only a clinician who knows you can weigh. Bring this product and its certificate to your physician or pharmacist before you start.

2% w/v, pharmaceutical grade
In stock · Dispatches 1-2 business days after payment

10 mg, lyophilised, research use only
In stock · Dispatches 1-2 business days after payment
Retatrutide
1 vial